The CPI-M on Thursday expressed deep concern that 76 life saving drugs have been taken off the customs duties exemption list and urged the government to review the decision.
"This gazette notification by the government has made these drugs more expensive," the Communist Party of India-Marxist said. "These drugs include anti-cancer, anti-AIDS and drugs for haemophilia patients.
"The government's reasoning is that this would protect the domestic drug companies.
"Now the prices of life saving drugs for patients dependent on imported drugs will rise by at least 22 percent. Worse is that where there are no domestic alternatives, patients have to rely on imported drugs alone."
This, it said, "will lead to severe economic hardships". It demanded that the government should reconsider this decision.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
